Table 1.

Demographics at entry of responders and non-responders in AbATE and Delay

Trial	Group	N	Age	Duration of diabetes (days)	Baseline C-peptide (nmol/L)
AbATE	Responders	19	13.5±1.33	40.7±1.97	0.76±.071
AbATE	Non-responders	30	12.2±0.84	41.0±1.43	0.70±.053
AbATE	Controls	25	12.3±0.82	37.6±7.58	0.67±0.056
Delay	Responders	13	12.15±1.09	210±20.6	0.588±0.07
Delay	Non-responders	18	13±1.06	219±18.7	0.639±0.08
Delay	Placebo	28	12.0±0.76	216±13.9	0.6±0.08

^*Responders were defined as having lost < 7.5% of their baseline C-peptide response at month 12 (6).